ArticleJournal of clinical and experimental neuropsychology2025
Using objective and subjective measures of mind wandering to predict progression to development of cognitive impairment and test associations with Alzheimer disease biomarkers.
Article in Journal of clinical and experimental neuropsychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Are the correlates of mind wandering consistent across younger and older adults?Psychological research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionMind wandering decreases in healthy aging, and in some cases, it is further reduced in Alzheimer disease (AD). However, little is known about how mind wandering changes during the preclinical phase of AD, which is a critical period for intervention. The present study aims to provide novel evidence for the utility of objective and subjective measures of mind wandering in evaluating the risk of developing cognitive impairment and their association with AD biomarkers.
methodsParticipants (
resultsObjective and subjective mind wandering significantly differed between progressors and cognitively stable participants at baseline and predicted likelihoods of progression. Moreover, baseline subjective mind wandering predicted progression beyond standard neuropsychological measures. Longitudinal models indicated that biomarker negative, but not positive, participants showed a significant reduction in RT CoV over time, possibly reflecting practice-related changes in performance. There were no longitudinal associations with subjective mind wandering.
conclusionsMind wandering is a common activity and may reflect a healthy cognitive system in older age. Subjective measures of mind wandering may be useful in predicting the later onset of cognitive impairment, while objective measures may be more sensitive to longitudinal changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.